Alzheimer disease: Can the exam predict the pathology?

Russell H. Swerdlow, Gregory A. Jicha

Research output: Contribution to journalEditorial

8 Scopus citations
Original languageEnglish
Pages (from-to)374-375
Number of pages2
Issue number6
StatePublished - Feb 7 2012

Bibliographical note

Funding Information:
Dr. Swerdlow serves on the editorial boards of Neurology®, the Journal of Alzheimer's Disease, Biochimica et Biophysica Acta, and Bioenergetics; has received speaker honoraria from Medivation, Inc. and Accera, Inc.; has served as a consultant for Eisai Inc.; and has received research support from Medivation, Inc., the NIH/NIA, Parkinson Foundation of the Heartland, Morgan Family Foundation, and Frank and Evangeline Thompson Alzheimer's Therapy Development Fund. Dr. Jicha has received funding for travel or speaker honoraria from the Alzheimer Association; serves as a consultant for Pfizer and Eli Lilly and Company; and receives research support from Pfizer Inc, Elan Corporation, Janssen, Medivation, Inc., Danone, and the NIH/NIA.

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Alzheimer disease: Can the exam predict the pathology?'. Together they form a unique fingerprint.

Cite this